Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Repeat Dosing of SADBE in Herpes Labialis
NCT03521479Phase 2Terminated
- Sponsor
- Squarex Pharma
- Start
- Mar 2018
- Primary completion
- Oct 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of squaric acid dibutyl ester in herpes labialis, sponsored by Squarex Pharma. Started Mar 2018; status: terminated.
02
Drugs
squaric acid dibutyl ester
03
Conditions
herpes labialis
Beyond the preview
Go deeper on NCT03521479.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03521479.